Mon, November 25, 2024
[ Mon, Nov 25th 2024 ]: Phil Bruner
The Best Tech Gifts for Fitness Geeks in 2024
Thu, November 14, 2024
[ Thu, Nov 14th 2024 ]: Nathan Burkes
The many benefits of excercise
Tue, November 12, 2024
[ Tue, Nov 12th 2024 ]: Nathan Burkes
The Best Exercises to Stay in Shape
Sat, June 10, 2017
[ Sat, Jun 10th 2017 ]: Market Wire
Lilly's Galcanezumab Significantly Reduces Number .. r Patients with Migraine: New Results Presented a
Sat, June 3, 2017
[ Sat, Jun 03rd 2017 ]: Market Wire
Lilly Builds Upon Body of Data for Abemaciclib wi .. monstrating Superior Progression-Free Survival in
Wed, May 31, 2017
[ Wed, May 31st 2017 ]: Market Wire
Lilly Announces Phase 3 RANGE Urothelial Cancer T .. Met Primary Endpoint, Improving Progression-Free
Wed, May 17, 2017
[ Wed, May 17th 2017 ]: Market Wire
Lilly to Present Results from Pivotal Breast Canc .. f Abemaciclib and New Portfolio Data at ASCO 2017
Fri, May 12, 2017
[ Fri, May 12th 2017 ]: Market Wire
Lilly Announces Positive Results for Three Phase .. r the Prevention of Episodic and Chronic Migraine
Thu, May 11, 2017
[ Thu, May 11th 2017 ]: Market Wire
BioLife Solutions Announces Q1 2017 Financial Results
Tue, May 9, 2017
[ Tue, May 09th 2017 ]: Market Wire
FDA Grants BAVENCIO (avelumab) Approval for a Common Type of Advanced Bladder Cancer
Thu, May 4, 2017
[ Thu, May 04th 2017 ]: Market Wire
BioLife Solutions to Report First Quarter 2017 Fi .. sults and Provide Business Update on May 11, 2017
Thu, April 20, 2017
[ Thu, Apr 20th 2017 ]: Market Wire
Lilly to Present Data for Galcanezumab for the Pr .. merican Academy of Neurology (AAN) Annual Meeting
Fri, April 14, 2017
[ Fri, Apr 14th 2017 ]: Market Wire
U.S. FDA Issues Complete Response Letter for Baricitinib
Thu, March 23, 2017
[ Thu, Mar 23rd 2017 ]: Market Wire
Lilly and the William Sansum Diabetes Center announce a five-year research collaboration
Fri, March 17, 2017
[ Fri, Mar 17th 2017 ]: Market Wire
First dedicated outcome trials of empagliflozin in chronic heart failure initiated
Thu, March 9, 2017
[ Thu, Mar 09th 2017 ]: Market Wire
BioLife Solutions Reports 4th Quarter and Full Year 2016 Results
Sat, March 4, 2017
[ Sat, Mar 04th 2017 ]: Market Wire
New Head-to-Head Data Shows Significantly Higher .. ltz (ixekizumab) Compared to Stelara (ustekinumab
Fri, March 3, 2017
[ Fri, Mar 03rd 2017 ]: Market Wire
Lilly Diabetes Becomes 'Official Diabetes Health Partner of NASCAR'
Thu, March 2, 2017
[ Thu, Mar 02nd 2017 ]: Market Wire
Lilly Announces Changes in Senior Management
Wed, February 15, 2017
[ Wed, Feb 15th 2017 ]: Market Wire
Additional results from pivotal RA-BEAM study pub .. of Medicine show baricitinib-treated patients de
Mon, February 13, 2017
[ Mon, Feb 13th 2017 ]: Market Wire
European Commission Approves Once-Daily Olumiant .. ts with Moderate-to-Severe Active Rheumatoid Arth
Wed, February 8, 2017
[ Wed, Feb 08th 2017 ]: Market Wire
Lilly's Trulicity (dulaglutide) Label Updated to .. ith Basal Insulin for Adults with Type 2 Diabetes
Thu, February 2, 2017
[ Thu, Feb 02nd 2017 ]: Market Wire
Hologic Launches Next-Generation NovaSure ADVANCE .. System for the Treatment of Abnormal Uterine Ble
Fri, January 13, 2017
[ Fri, Jan 13th 2017 ]: Market Wire
U.S. FDA Extends Review Period for Baricitinib, an Investigational Rheumatoid Arthritis Treatment
Wed, January 11, 2017
[ Wed, Jan 11th 2017 ]: Market Wire
Lilly and Merck Expand Immuno-Oncology Collaboration
Wed, January 4, 2017
[ Wed, Jan 04th 2017 ]: Market Wire
U.S. FDA approves supplemental New Drug Applicati .. in product labels for Synjardy (empagliflozin/met
Fri, December 16, 2016
[ Fri, Dec 16th 2016 ]: Market Wire
CHMP Recommends Approval of Lilly's Baricitinib f .. th Moderate to Severe Active Rheumatoid Arthritis
Thu, December 15, 2016
[ Thu, Dec 15th 2016 ]: Market Wire
BASAGLAR (insulin glargine injection 100 units/mL .. ng-Acting Basal Insulin, Is Now Available in U.S.
Mon, December 12, 2016
[ Mon, Dec 12th 2016 ]: Market Wire
U.S. FDA approves Synjardy XR (empagliflozin/metf .. -release) tablets for adults with type 2 diabetes
Thu, December 8, 2016
[ Thu, Dec 08th 2016 ]: Market Wire
Lilly Presents neoMONARCH Phase 2 Data on Abemaciclib in Early-Stage Breast Cancer
Wed, November 23, 2016
[ Wed, Nov 23rd 2016 ]: Market Wire
Lilly Announces Top-Line Results of Solanezumab Phase 3 Clinical Trial
Mon, November 14, 2016
[ Mon, Nov 14th 2016 ]: Market Wire
New Analyses of Phase 3 Trials Show Improvements .. oms Following Treatment with Baricitinib Across D
Sun, November 13, 2016
[ Sun, Nov 13th 2016 ]: Market Wire
Jardiance (empagliflozin) consistently reduced th .. h in adults with type 2 diabetes regardless of th
Wed, November 9, 2016
[ Wed, Nov 09th 2016 ]: Market Wire
COLUMBUS Phase 3 Study Results in BRAF-Mutant Mel .. at Society for Melanoma Research Annual Congress
Thu, November 3, 2016
[ Thu, Nov 03rd 2016 ]: Market Wire
Lilly Presents Clinical Efficacy, Safety and Pati .. Baricitinib in Patients with Rheumatoid Arthriti
Wed, November 2, 2016
[ Wed, Nov 02nd 2016 ]: Market Wire
New data from pivotal RA-BEACON study show signif .. reported outcomes in rheumatoid arthritis patient
Mon, October 17, 2016
[ Mon, Oct 17th 2016 ]: Market Wire
Lilly Partners with the National Cancer Institute .. h through New Program under Cancer Moonshot Initi
Sat, October 8, 2016
[ Sat, Oct 08th 2016 ]: Market Wire
New Data on the Combination of Lilly's ALIMTA (pe .. A (pembrolizumab) Show a Near-Doubling of Objecti
Thu, October 6, 2016
[ Thu, Oct 06th 2016 ]: Market Wire
Technical Roundup on Drug Makers Stocks -- Tonix .. rma, Retrophin, Heron Therapeutics, and GW Pharma
Wed, October 5, 2016
[ Wed, Oct 05th 2016 ]: Market Wire
Biotech Stocks Technical Reports -- Peregrine Pha .. rapeutics, Aratana Therapeutics, and Vanda Pharma
Mon, October 3, 2016
[ Mon, Oct 03rd 2016 ]: Market Wire
Biotechs with Key Corporate Developments
Fri, September 30, 2016
[ Fri, Sep 30th 2016 ]: Market Wire
The Medical Device Industry's Focus on Cardio and Cardiovascular Needs
Thu, September 29, 2016
[ Thu, Sep 29th 2016 ]: Market Wire
Awareness Continues to Grow for Medical Uses of Cannabis
Tue, September 27, 2016
[ Tue, Sep 27th 2016 ]: Market Wire
ProNAi Licenses Oncology Drug Targeting DNA Damag .. ckpoint Kinase 1 (Chk1) From CRT Pioneer Fund, UK
Mon, September 26, 2016
[ Mon, Sep 26th 2016 ]: Market Wire
The Bioscience and Biotechnology Sector Developments in Cancer Therapy
Fri, September 23, 2016
[ Fri, Sep 23rd 2016 ]: Market Wire
Shire to Showcase Continued Innovation and Leader .. uring European Society for Immunodeficiencies Bie
Thu, September 22, 2016
[ Thu, Sep 22nd 2016 ]: Market Wire
Biotech Stocks on Investors' Radar -- Portola Pha .. bluebird bio, Auris Medical, and Cerulean Pharma
Wed, September 21, 2016
[ Wed, Sep 21st 2016 ]: Market Wire
Research Reports Coverage on Healthcare Stocks -- Aetna, Anthem, Humana, and BioScrip

Susan Anderson Upgraded (ANF) to Hold and Decreased Target to $13 on, Jan 4th, 2017

Susan Anderson of FBR Capital, Upgraded "Abercrombie & Fitch Co." (ANF) to Hold and Decreased Target from $14 to $13 on, Jan 4th, 2017.

Susan has made no other calls on ANF in the last 4 months.



There is 1 other peer that has a rating on ANF. Out of the 1 peers that are also analyzing ANF, all agrees with Susan's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Randal Konik of "Jefferies" Downgraded from Strong Buy to Hold on, Tuesday, January 3rd, 2017


Similar Health and Fitness Publications
[ Tue, Jan 03rd 2017 ]: WOPRAI
Category: Stocks and Investing
[ Tue, Mar 08th 2016 ]: WOPRAI
Category: Stocks and Investing
[ Tue, Jan 26th 2016 ]: WOPRAI
Category: Stocks and Investing
[ Tue, Jan 19th 2016 ]: WOPRAI
Category: Stocks and Investing
[ Tue, Jan 19th 2016 ]: WOPRAI
Category: Stocks and Investing
[ Mon, Oct 19th 2015 ]: WOPRAI
Category: Stocks and Investing
[ Thu, Aug 27th 2015 ]: WOPRAI
Category: Stocks and Investing
[ Tue, Jun 30th 2015 ]: WOPRAI
Category: Stocks and Investing
[ Tue, Feb 24th 2015 ]: WOPRAI
Category: Stocks and Investing
[ Thu, May 22nd 2014 ]: WOPRAI
Category: Stocks and Investing
[ Thu, Nov 07th 2013 ]: WOPRAI
Category: Stocks and Investing
[ Wed, Oct 02nd 2013 ]: WOPRAI
Category: Stocks and Investing